Journal article
W. Tamayo-Agudelo, M. J. Jaén-Moreno, María O. León-Campos, J. Holguín-Lew, Rogelio Luque-Luque, V. Bell
PLoS ONE, 2019
PLoS ONE, 2019
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Tamayo-Agudelo, W., Jaén-Moreno, M. J., León-Campos, M. O., Holguín-Lew, J., Luque-Luque, R., & Bell, V. (2019). Validation of the Spanish-language Cardiff Anomalous Perception Scale. PLoS ONE.
Chicago/Turabian
Click to copy
Tamayo-Agudelo, W., M. J. Jaén-Moreno, María O. León-Campos, J. Holguín-Lew, Rogelio Luque-Luque, and V. Bell. “Validation of the Spanish-Language Cardiff Anomalous Perception Scale.” PLoS ONE (2019).
MLA
Click to copy
Tamayo-Agudelo, W., et al. “Validation of the Spanish-Language Cardiff Anomalous Perception Scale.” PLoS ONE, 2019.
BibTeX Click to copy
@article{w2019a,
title = {Validation of the Spanish-language Cardiff Anomalous Perception Scale},
year = {2019},
journal = {PLoS ONE},
author = {Tamayo-Agudelo, W. and Jaén-Moreno, M. J. and León-Campos, María O. and Holguín-Lew, J. and Luque-Luque, Rogelio and Bell, V.}
}
Abstract
The Cardiff Anomalous Perceptions Scale (CAPS) is a psychometric measure of hallucinatory experience. It has been widely used in English and used in initial studies in Spanish but a full validation study has not yet been published. We report a validation study of the Spanish-language CAPS, conducted in both Spain and Colombia to cover both European and Latin American Spanish. The Spanish-language version of the CAPS was produced through back translation with slight modifications made for local dialects. In Spain, 329 non-clinical participants completed the CAPS along with 40 patients with psychosis. In Colombia, 190 non-clinical participants completed the CAPS along with 21 patients with psychosis. Participants completed other psychometric scales measuring psychosis-like experience to additionally test convergent and divergent validity. The Spanish-language CAPS was found to have good internal reliability. Test-retest reliability was slightly below the cut-off, although could only be tested in the Spanish non-clinical sample. The scale showed solid construct validity and a principal components analysis broadly replicated previously reported three component factor structures for the CAPS.